Erasca (ERAS) Assets (2020 - 2026)
Erasca posted quarterly Assets of $461.2 million for Q1 2026, down 2.12% year-on-year from $471.2 million in Q1 2025, and up 16.43% on a QoQ basis from $396.2 million in Q4 2025.
Erasca (ERAS) has 7 years of Assets data on file, last reported at $461.2 million in Q1 2026.
- For the quarter ending Q1 2026, Assets fell 2.12% year-over-year to $461.2 million; the trailing twelve-month figure through Mar 2026 stood at $461.2 million (down 2.12% YoY), and the FY2025 full-year result was $396.2 million, down 21.17% from the prior year.
- Assets for Q1 2026 stood at $461.2 million, up from $396.2 million in the prior quarter.
- Across five years, Assets topped out at $528.9 million in Q3 2024 and bottomed at $370.0 million in Q1 2024.
- The 5-year median for Assets is $446.4 million (2022), against an average of $454.5 million.
- The widest annual swing landed in 2022, when Assets soared 111.43%; it then fell 23.23% in 2023.
- A 5-year view of Assets shows it stood at $514.9 million in 2022, then dropped by 23.23% to $395.3 million in 2023, then grew by 27.13% to $502.5 million in 2024, then slipped by 21.17% to $396.2 million in 2025, then rose by 16.43% to $461.2 million in 2026.
- The last three Assets figures came in at $461.2 million (Q1 2026), $396.2 million (Q4 2025), and $420.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - | 461.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 461.23 Mn |
| Dec 31, 2025 | 396.15 Mn |
| Sep 30, 2025 | 420.40 Mn |
| Jun 30, 2025 | 445.39 Mn |
| Mar 31, 2025 | 471.24 Mn |
| Dec 31, 2024 | 502.53 Mn |
| Sep 30, 2024 | 528.90 Mn |
| Jun 30, 2024 | 525.74 Mn |
| Mar 31, 2024 | 370.02 Mn |
| Dec 31, 2023 | 395.30 Mn |
| Sep 30, 2023 | 419.41 Mn |
| Jun 30, 2023 | 440.66 Mn |
| Mar 31, 2023 | 467.54 Mn |
| Dec 31, 2022 | 514.91 Mn |
| Sep 30, 2022 | 446.43 Mn |
| Jun 30, 2022 | 444.82 Mn |
| Mar 31, 2022 | 475.47 Mn |
| Dec 31, 2021 | 501.42 Mn |
| Sep 30, 2021 | 521.95 Mn |
| Jun 30, 2021 | 210.38 Mn |
| Dec 31, 2020 | 124.83 Mn |